Please assess the completion status of the following clinical trial:

Trial Title: Lactoferrin for Prevention of COVID-19 in Health Care Workers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Man or woman over 18 and under 60 years old~* Physicians or nurses or nurse assitant who work in areas of care for patients with COVID-19 (emergency, hospitalization, and Intensive Care Unit) in hospitals in Lima, Peru.~* Healthy participants, without COVID-19 suggestive symptoms~* Participant who wants to participate and signs the informed consent.~Exclusion Criteria:~* Participant who had a previous diagnosis of COVID-19.~* Participant positive in the initial screening for IgM or IgG or a positive RT-PCR for SARS-CoV-2.~* Participant with the following comorbidities: hypertension, coronary heart disease, diabetes mellitus, obesity, chronic lung disease, cancer, kidney failure, or other hematological disease.~* Pregnant woman.~* Participant that are part of another clinical trial or are taking any supplement or preventive treatment for COVID-19.~* Participant with known allergy to cow's milk protein.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 59 Years
- Healthy Volunteers: t

Study Arms:
- Bovine Lactoferrin (Type: EXPERIMENTAL): Bovine Lactoferrin plus standard measures of personal protection.
- Maltodextrin (Type: PLACEBO_COMPARATOR): Maltodextrin plus standard measures of personal protection.

Based on this trial design, predict the completion outcome and termination type (if applicable).